Objective: The current study aimed to identify the predictive values of psychological factors that are evaluated by the Symptoms Checklist-90 (SCL-90) for acute mountain sickness (AMS). Methods: The subjects (n = 285, non-acclimatized young Chinese men), who were recruited in July 2013, completed a case report questionnaire. In addition, their vital signs (heart rate [HR], blood pressure and pulse oxygen saturation) were measured, and their psychological factors were examined using the SCL-90 at sea level. AMS was diagnosed using the Lake Louise self-assessment scoring system in the morning of the second day after their arrival at 3450 m. Results: Of the nine factors of the SCL-90, the AMS patients (AMS score ≥ 3) were characterized by significantly higher scores for baseline somatization [14.0 (5.0) vs. 13.0 (3.0), p b 0.001], obsession-compulsion, depression, anxiety and hostility compared with the non-AMS group (all p values b 0.05). Spearman's correlation analyses revealed associations between AMS scores and somatization (r = 0.316, p b 0.001), depression, anxiety, obsession-compulsion, interpersonal sensitivity, hostility, phobic anxiety, paranoid ideation and psychoticism scores (all p values b 0.001). Although all nine factors were associated with AMS in a univariate regression (all p b 0.05), a further adjusted logistic regression analysis indicated that only baseline somatization score (odds ratio = 1.129, p = 0.001) was an independent predictor of AMS. Furthermore, some non-AMS often-occurred symptoms (paresthesia, shortness of breath, reduced activity and tinnitus) were also found to be associated with the baseline SCL-90 scores. Conclusion: AMS is correlated with the baseline somatization score at sea level, which was measured using the SCL-90. A higher baseline somatization score is also an independent predictor of AMS.
Introduction
Acute mountain sickness (AMS) describes a syndrome that occurs after exposure to altitudes of 2500 m or higher [1, 2] , which is diagnosed by Lake Louise self-score system (LLS) [2] . The incidence of AMS has been reported to range from 10 to 85% [1, 3] . AMS is a critical medical issue that threatens tourists, workers and migrants who move from lower altitudes to a high altitude because of its high incidence, the resulting discomfort and the deadly risk of high-altitude cerebral edema (HACE).
Previous researchers have identified many risk factors for AMS [4, 5] , including decreased pulse oxygen saturation (SpO 2 ), increased HR, evaluated cerebral hemodynamics, faster climbing speeds and higher altitudes [6, 7] . Furthermore, vasoconstriction, vasodilatation and increased intracranial pressure or higher perfusion pressure may participate in the mechanisms of AMS [2, 8, 9] . Additionally, the physiological or psychological activation of the sympathetic nervous system has also been indicated as a consequence of high-altitude exposure and as a risk factor for AMS [1, 2] .
Previous studies have paid particular attention to the physiological factors associated with AMS or high-altitude headache [10] , but few of them have focused on the psychological aspects [11, 12] . Although a few studies have focused on the effects of high altitude on mental behavior [13] and psychiatric symptoms, the associations between AMS and the associated psychiatric symptoms have not been fully investigated. New onsets of anxiety and depression after high-altitude exposure have been reported. Samuel J. Oliver and colleagues investigated physiological and psychological illness symptoms at high altitude and found that anxiety contributed to the symptom burden when altitude was gained [11] . Furthermore, a relationship between changes in negative mood states, including anxiety and cognitive performance after hypoxia exposure [14] may account for AMS symptoms. Thus, psychiatric symptoms may be associated with or even predict AMS. In addition, AMS is diagnosed using a subjective self-report questionnaire; thus, psychological factors and emotional states are critical in relation to AMS, especially for psychological and neurological clinical manifestations, which include headache, dizziness and insomnia [2] .
In addition to the AMS symptoms, many other complaints (non-LLS related symptoms), such as the symptoms included in the environmental symptoms questionnaire (ESQ-III), account for a large proportion of the discomforts of high-altitude exposure. These symptoms may also limit daily work and life at high altitudes, although they are not essential for an AMS diagnosis. Therefore, it is critical and urgent to study both the AMS-related problems and the non-LLS related symptoms that affect individuals coming to high altitudes from lower altitudes. We postulated that baseline psychological factors would be associated with or predict AMS, and conducted this study with the aim of identifying the relationships between AMS and baseline psychological factors, as assessed using the Symptoms Checklist-90 (SCL-90).
Methods

Participants and procedures
Participants
This prospective observational study was designed to identify the predictive values of baseline SCL-90 scores at sea level for AMS after high-altitude exposure. The participants (285 young Chinese soldiers on an altitude-training mission) were recruited in July 2013 at sea level (400 m) in Chongqing and were assessed at 3450 m after a fourday bus trip. The inclusion criteria were as follows: healthy Chinese men between 16 and 30 years old; subjects did not take medication or receive any intervention before ascending. However, severe headache subjects were treated with NSAIDs or Sanlietong (Taiji medicine, Xi'an, China) as necessary at high altitude. Subjects with any of the following conditions were excluded: cerebrovascular diseases, cardiovascular diseases, neuro-psychosis, respiratory diseases, malignant tumors and disorders of the liver or kidneys.
The study was thoroughly explained to all of the volunteers, and all of them signed informed consent forms prior to their examinations. This study was reviewed and approved by the Ethics Committee of Xinqiao Hospital at the Second Clinic Medical College of the Third Military Medical University.
Procedures
The baseline parameters were examined in Chongqing before their trip using structured case report forms [i.e., age, body mass index (BMI), smoking and alcohol consumption]. The physiological measurements were conducted during routine examinations prior their travel. Blood pressure was measured using a sphygmomanometer (HEM-6200, OMRON, China) after a 30-min rest period. The subjects' HR and SpO 2 were also measured using a pulse oximeter (NONIN-9550, Nonin Onyx, USA). Histories of traumatic brain injury, psychiatric disorder/ treatment, physical injuries, AMS (high-altitude headache) and high-altitude exposure over the past 2 years were also recorded on the case report form. The primary version of the SCL-90 was used to measure the subjects' psychiatric symptoms (Appendix 1) [15] [16] [17] . The subjects were questioned using the SCL-90 checklist, which includes 90 items (9 factor categories). These items were presented out of order and were translated into Chinese [17] . Our trained physicians performed the physiological evaluations of HR, blood pressure and SpO 2 .
The AMS questionnaires were performed at 3450 m (Xin Duqiao, 8:00-10:00 in the morning on the fifth day after one night's rest, Fig.  1A ) after the participants had completed a four-day trip from sea level (400 m from Chongqing) via bus. AMS-related symptoms (i.e. the LLS symptoms, headache, dizziness, gastrointestinal symptoms, difficulty sleeping and fatigue/weakness) and non-LLS related symptoms were recorded. AMS was diagnosed based on the LLS scores. Subjects whose LLS score was 3 or higher and who had a headache were identified as having AMS. Furthermore, many other frequently occurring non-LLS related symptoms that threaten health and daily life at high altitudes, including lethargy, constipation, dim eyesight, dyspnea and cough, were also queried in the case report form (as present or not present).
Statistical analysis
Normally distributed variables [i.e., age, BMI, HR, systolic blood pressure (SBP), diastolic blood pressure (DBP) and SpO 2 ] were expressed as the mean ± standard deviation (SD). Non-normally distributed variables (the nine factors of the SCL-90) were expressed as median (quartile range). The AMS+ (with AMS) and AMS − (without AMS) groups were compared using independent samples T tests or Mann-Whitney U-tests, as appropriate. The relationships between AMS score and each of the aforementioned parameters were analyzed using Spearman's correlations. Univariate and adjusted logistic regressions were performed to identify the independent variables associated with AMS (Fig. 1B , the statistical analysis chart).
Results
Data were excluded if the subjects' demographic information or other items were missing (e.g., lack of demographic information, AMS symptoms or the sub-items of the SCL-90); totally 280 valid case report forms and examinations were collected. The mean age and BMI of the subjects in this study were 20.88 ± 2.42 years and 21.28 ± 2.28 kg/ m 2 respectively. The percentages of participants who smoked or consumed alcohol were 26.0% and 4.5% respectively. At sea level, the mean SBP, DBP, HR and SpO 2 were 112.44 ± 10.94 mmHg, 67.64 ± 8.84 mmHg, 70.20 ± 9.82 beats per min and 97.37 ± 1.15%. The incidences of AMS, headache and dizziness were 24.7%, 41.9% and 50.2% ( Fig. 2A) . Furthermore, the incidences of non-LLS related symptoms were shown in Fig. 2B . The descriptive statistics for the nine factors of the SCL-90 were shown in Fig. 3(a-i) . Most of the 280 individuals were characterized by normal or mild scores on the nine factors of the SCL-90 (Table 1) . More specifically, 186 subjects had a somatization score between 12 and 24, and 135 had an anxiety score between 10 and 20. Mild obsession-compulsion characterized a proportion of the participants (185). Regarding depression, 119 participants reported mild depression. The reported incidences of positive hostility (130), phobic anxiety (70) and paranoid ideation (111) symptoms were somewhat lower. Furthermore, 95 individuals developed mild psychoticism (Table 1) .
In terms of the demographic data, the age and BMI did not significantly differ between the AMS+ and AMS− groups. Furthermore, baseline SBP, DBP, HR and SpO 2 did not differ between two groups (all p values N 0.05). Of the nine factors of the SCL-90, somatization, obsession-compulsion, depression and anxiety scores were significantly higher in the AMS+ group than in the AMS− group (p b 0.001). Furthermore, the hostility, phobic anxiety, paranoid ideation and psychoticism scores also showed significant differences between two groups (all p values b 0.001). Most of the nine factors revealed differences between the groups with and without headache and dizziness. The differences in physiological and psychological parameters between the groups are presented in Table 2 .
Spearman's correlation analyses indicated relationships between AMS scores and baseline BMI, somatization, obsession-compulsion, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation and psychoticism scores (all p values b 0.05). Regarding the nervous symptoms of AMS, headache was related to baseline scores for somatization, obsession-compulsion, depression, hostility, phobic anxiety, paranoid ideation and psychoticism (all p values b 0.05). Dizziness was associated with somatization, obsession-compulsion, interpersonal sensitivity, depression, anxiety, hostility, paranoid ideation and psychoticism (all p-values b 0.05), though not with phobic anxiety (p = 0.164). The associations between SCL-90 factors and AMS and its symptoms were shown in Table 3 .
Univariate regressions were performed for each single variable. However, the baselines for age, BMI, SBP, DBP, HR and SpO 2 were not associated with AMS (all p values N 0.05). We have also indicated that A further adjusted logistic regression analysis was performed to identify that the factors were independently associated with AMS; this analysis indicated that only baseline somatization (β = 0.121; OR: 1.129; 95% CI: 1.053-1.210; p = 0.001) was still a predictor of AMS independent of other confounding factors (Table 4) .
The baseline of somatization was an independent predictor for AMS. Furthermore, we have also examined the SCL-90 characteristics of AMS at altitude. The results showed that only higher somatization score and depression score were independent risk factors for AMS (Appendix 2, Tables 1A-3A) .
Regarding the association between the alterations of SCL-90 and AMS, we have also analyzed the differences and regression for AMS in the alterations of the SCL-90. Only the change of somatization score was associated with AMS score (r = 0.188, p b 0.001). Furthermore, only change of somatization was still predictor for AMS (β = 0.132, OR = 1.141, 95% CI: 1.041-1.250, p = 0.05).
In order to further identify the roles of SCL-90 in AMS, we have performed the analyses between the groups with a cut-off at 4 for the LLS. Tables 4A-5A) .
Additionally, we investigated the incidences of non-LLS related symptoms that commonly occurred after high-altitude exposure, including paresthesia (24.7%), shortness of breath (26.2%), chest pain (19.5%), tinnitus (21.7%), reduced activity (23.6%), dim eyesight (9.0%), lethargy (14.2%), constipation (13.5%), cough (7.5%) and dyspnea (8.2%; Fig. 2B ). The differences in SCL-90 factor scores were also tested in relation to the four main symptoms (incidence N 20%). We observed that the somatization, obsession-compulsion, interpersonal sensitivity, depression, anxiety and hostility scores were significantly higher in individuals with paresthesia than in those without paresthesia. Moreover, higher baseline scores for somatization, obsession-compulsion and depression scores were accompanied by a greater reduction in activity (Table 5 ). The differences between those with and without shortness of breath groups in the SCL-90 factors have been identified (Table 5) .
Furthermore, the non-LLS related symptoms' characteristics of SCL-90 at altitude has also been carried out and attached in Appendix 2 (Table 6A ).
Discussion
The main finding of our study was that SCL-90 scores at low altitude were associated with risk of AMS. In specific a tendency for somatization was a significant predictor of AMS. Given the subjective nature of questionnaires such as the LLS to diagnose AMS, this is noteworthy.
We observed associations between the baselines of harmful psychological symptoms as well as AMS and the associated headache, dizziness, and nervous symptoms. Additionally, we found that the baseline somatization score is an independent predictor of AMS at 3450 m. Finally, we have also observed the differences between the SCL-90 factors and the non-LLS related symptoms.
AMS was associated with SCL-90 factors at both altitudes
Previous studies have focused on the associations between high altitude mountaineering and psychological factors [18] and have indicated the partial association of AMS with psychological factors through metaanalysis and field trials [19] . AMS symptoms and progression have been also reported in normobaric hypoxia equivalent which was similar to our study [20] . However, the predictive values of the baseline psychological factors for AMS have not been fully investigated. The current study further reveals that individuals with AMS have higher baseline somatization, depression, anxiety and obsession-compulsion scores. Subjects susceptible to AMS have been found to be more anxious. Additionally, investigators have proposed the term "acute hypoxic physiological anxiety" to describe the anxiety that occurs after the arrival at altitudes and it is associated with AMS [21] . AMS patients showed more baseline somatization symptoms score at sea level prior to highaltitude exposure, a finding that is in accordance with the results of previous studies on AMS symptomatology [21] . AMS severity was also positively correlated with the baseline scores for somatization, anxiety and depression, highlighting the roles of psychological factors in the AMS diagnosis. It is possible that anxiety and depression reactions to high-altitude exposure lead to self-reported AMS symptoms [14, 22] , but subjective feelings about symptoms should not be ignored.
The emotional and behavioral changes resulting from high-altitude exposure have been indicated in previous studies [13] .We have also identified the associations between AMS and SCL-90 at altitude. The AMS individuals had higher somatization, depression, anxiety and obsession-compulsion scores, indicating that anxiety and depression may affect the incidence of AMS. Furthermore, the average somatization score was significantly higher in the AMS+ group than in the AMS− group, indicating that the AMS patients have more somatization symptoms, which is in accordance with the previous studies on AMS symptomatology [23] . The SCL-90 characteristics of AMS may be useful for the clinical practice in treatment of AMS. However, the associations and predictive values of baseline emotional states prior to high-altitude exposure have not been widely investigated. Thus, the impact of baseline psychological states before high-altitude exposure on AMS should be of great importance. Furthermore, headache and dizziness were the most frequently reported nervous symptoms of AMS; these symptoms may be more likely to be affected by psychological factors than other symptoms. Therefore, we analyzed these two symptoms in particular. The associations between AMS and the psychological states of anxiety and depression may be caused by their relationships with AMS-related symptoms, such as headache and dizziness, which is partially in accordance with previous reports [14, 22, 24] . A hypobaric chamber simulation study indicated the associations between anxiety and the symptomatology of AMS and the effects of anxiety on performance [14] . Studies at sea level have shown a relationship between headache (including episodic headache, chronic cluster headache and tensiontype headache) and anxiety or depression [25, 26] . Further studies have demonstrated that headaches at high altitude present with the clinical characteristics of migraine, cluster or episodic headaches [27, 28] . The relationship between anxiety (panic attacks) and headache has also been indicated [29] , which is in accordance with our finding that headache patients had a higher baseline anxiety level. Our previous study also showed that somatic symptoms were associated with anxiety severity after high-altitude exposure [24, 30] .
Dizziness is another nervous complaint of AMS that may be affected by psychological risk factors and may result in somatic symptoms. However, fewer studies have indicated a relationship between dizziness and anxiety, although depression-induced dizziness has been reported [31, 32] . In this study, we have also observed the association between dizziness and the basic psychological parameters on the SCL-90. Although AMS is not characterized by higher scores for interpersonal sensitivity, the distribution was more varied in AMS+ individuals than in AMS − individuals.
Associations between SCL-90 and non-LLS related symptoms
Many symptoms that frequently occur after high-altitude exposure were not used for the AMS diagnosis. We further analyzed the associations between the SCL-90 factors and the non-AMS symptoms with an incidence N 20%, including paresthesia, reduced activity, shortness of breath and tinnitus. Similar to the AMS-related symptoms, paresthesia, reduced activity and shortness of breath were associated with significantly higher scores on most of the SCL-90 factors at baseline level, especially somatization, depression and anxiety. It is not difficult to understand that baseline psychological factors result in paresthesia and reduced activities as a result of fear, anxiety and depression. Shortness of breath may be caused by somatization and anxiety about addressing hypoxia, or it may be caused by hypoxia per se [33, 34] . Although paresthesia, shortness of breath and tinnitus were not included in the diagnostic criteria, the diagnostic value of these symptoms should be given proper attention.
Based on the discussion above, the non-AMS related symptoms with a high incidence may be potential symptoms, and they should receive proper attention. The non-AMS symptomatology should also been prevented and treated promptly.
Baseline somatization score as an independent predictor of AMS
After adjusting for other parameters, only the baseline somatization score remained an independent predictor of AMS. The sub-items of somatization include headache, cardiovascular, gastrointestinal and respiratory symptoms. In the past several decades, most studies have given greater attention to physiological and genetic risk factors and have identified some valuable factors that contribute to AMS [9, [35] [36] [37] . Though anxiety has a widely demonstrated association with AMS or high-altitude exposure, the baseline anxiety score was not an independent predictor of AMS in the adjusted regression. However, the baseline somatization score predicted AMS in the adjusted analysis that excluded the effects of the confounding factors. Combined with the current results, somatization symptoms, emotional disorders and psychiatric symptoms may be considered risk factors, predictors or even clinical manifestation of AMS that need to be investigated in further studies.
Limitations
The participants in our study were all young Chinese men, which could have generated an age or gender bias; our future studies will address these possible biases. Another limitation of the current study is that further detailed examinations of the mechanisms and other methods for measuring anxiety and depression were not performed; such examinations should be performed in future studies.
Conclusion
AMS is associated with the baseline somatization and other symptom scores measured by SCL-90. However, only the somatization score at baseline was a predictor of AMS independent of other confounding factors; thus, further studies of the AMS mechanisms and possible clinical applications are warranted.
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Conflict of interest statement
The authors declare that there is no conflict of interests. 
